Company Profiles

driven by the PitchBook Platform

AnTolRx

Description

Operator of a biotechnology company for the treatment of autoimmune diseases. The company focuses on the development of novel nanoparticle-based therapies to promote antigen-specific immune tolerance specifically for the treatment of Type 1 diabetes.

2015

Founded

PRIVATE

Status

Series A

Latest Deal Type

$4M

Latest Deal Amount

$4M

Total Amount Raised

3

Investors

Description

Operator of a biotechnology company for the treatment of autoimmune diseases. The company focuses on the development of novel nanoparticle-based therapies to promote antigen-specific immune tolerance specifically for the treatment of Type 1 diabetes.

Website:

www.antolrx.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Other Pharmaceuticals and Biotechnology

Primary Office

One Kendall Square, Building 1400 West Suite 14303 Cambridge, MA 02139United States +1 (617) 945-8468
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore AnTolRx's full profile, request a free trial.

    AnTolRx Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    AnTolRx Cap Table

    Stock# of Shares
    Authorized
    Par ValueDividend Rate (%)Original
    Issue Price
    LiquidationLiquidation
    Pref. Multiple
    Conversion
    Price
    % Owned

    AnTolRx Investors (3)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    Juvenile Diabetes Research FoundationLimited PartnerMinority000 0000000 0000
    Orion Equity PartnersOtherMinority000 0000000 0000
    PfizerCorporationMinority000 0000000 0000
    Juvenile Diabetes Research Foundation Limited Partner
    Orion Equity Partners Other
    Pfizer Corporation

    AnTolRx Executive Team (2)

    NameTitleBoard
    Seat
    Contact
    Info
    Mark CarthyCo-Founder, President, Chief Executive Officer and Board Member
    Francisco QuintanaScientific Founder & Board Member
    Mark Carthy Co-Founder, President, Chief Executive Officer and Board Member
    Francisco Quintana Scientific Founder & Board Member

    AnTolRx Board Members (3)

    NameRepresentingRoleSinceContact
    Info
    Francisco QuintanaAnTolRxScientific Founder & Board Member000 0000
    Mark CarthyAnTolRxCo-Founder, President, Chief Executive Officer and Board Member000 0000
    Satish JindalAnTolRxBoard Member000 0000
    Francisco Quintana Scientific Founder & Board Member AnTolRx
    Mark Carthy Co-Founder, President, Chief Executive Officer and Board Member AnTolRx
    Satish Jindal Board Member AnTolRx
    Request full access to PitchBook